Pixantrone dimaleate
Pixuvri (pixantrone dimaleate) is a small molecule pharmaceutical. Pixantrone dimaleate was first approved as Pixuvri on 2012-05-10. It has been approved in Europe to treat non-hodgkin lymphoma.
| Trade Name | Pixuvri |
|---|---|
| Common Name | Pixantrone dimaleate |
| Indication | non-hodgkin lymphoma |
| Drug Class | Antineoplastics, anthraquinone derivatives |
